Get Permission Haleema A, Lessitha N K, Haneef, and Paul: A comparative study of central corneal thickness in patients with diabetes and without diabetes mellitus


Introduction

Due to sedentary lifestyle and population aging, diabetes mellitus is becoming increasingly and seriously prevalent lifestyle health problem worldwide.1 Diabetes mellitus is characterized by chronic hyperglycemia, which causes increased micro and macro vascular complication, if not managed properly in time, can affect all organs of our body. It can also severely affect ocular tissue, with damage occurring even during the early stages of the disease. 2 Even though diabetic retinopathy is the major and most serious diabetic complication in eye,3, 4 other parts of eye are also affected significantly (30% of diabetic patients).5 Up to 70% of diabetic patients can develop corneal changes and are also difficult to manage.2 These include delayed wound healing due to cellular dysfunction, 6 increased risk of infection and stromal fibrosis due to weakening of the epithelial barrier and its improper function, 7 diminished corneal sensation 8 and recurrent corneal erosion due to abnormal adhesions of the corneal epithelium to the underlying basement membrane. 9

Several studies including- studies by Daniel.H.W.Su and et al, 10 Xiao-Yang Luo and et al 11 and Hoda M. K. Elsobky and et al 12 showed that central corneas tend to be thicker in diabetes and hyperglycemia independent of age and IOP levels. But some studies disagree with these observations, like those by Amira El-Agamy and et al13 and Mm Choo and et al 14 where, they observed no significant association between diabetes and central corneal thickness.

Central corneal thickness (CCT) is widely considered as a constant parameter, so are measured only once during follow up in our daily clinical practice 15 and it ranges from 551 to 565μ. Central corneal thickness can interfere in the accurate intraocular pressure (IOP) reading especially with Goldman applanation tonometry, which is the gold standard for measuring IOP.16 For every 25 μm increase in CCT, there is 1 mm Hg change in IOP; especially with CCT greater than 550 μm. 17 Thick cornea overestimate IOP and thin cornea underestimate it. 18 IOP is an important treatable and causative risk factor of glaucoma. So, for accurate measurement of IOP, determination of CCT is also important. CCT is also an important parameter in refractive corneal surgery for determining flap size, for assessing cornea for any ectasia post operatively, for assessing corneal diseases like- keratoconus, dystrophies, ectasia and edema, and for assessing donor cornea.

In this study we determine whether diabetes has any effect over central corneal thickness.

Materials and Methods

Research question

Is the central corneal thickness of diabetes mellitus patients thicker than that of non-diabetes mellitus patients?

Objectives of the study

  1. To evaluate central corneal thickness in diabetic and non-diabetic patients

  2. To compare the central corneal thickness in diabetic and non-diabetic patients

  3. To compare central corneal thickness among the sub groups of diabetic patients – patients with no diabetic retinopathy, with non-proliferative diabetic retinopathy and proliferative diabetic retinopathy.

Hypothesis

Diabetes mellitus may be associated with thicker corneas.

Study design

Comparative observational study.

Study population

  1. Group 1: Diabetes patients. It is divided in to 3 subgroups:

    1. Subgroup 1- no diabetic retinopathy

    2. Subgroup 2- non proliferative diabetic retinopathy

    3. Subgroup 3- proliferative diabetic retinopathy

  2. Group 2: Non diabetic patients

Study duration

One and half years

Sample size n=z1+α2+z1-β2s12+s22x¯1-x¯22

n= 106 in one group

Total sample size 106 X 2= 212

Sampling method

Convenient sampling method

Inclusion criteria

  1. Patients of 35 to 75 years of age.

  2. Patients who are diagnosed cases of diabetes mellitus, according to the American Diabetes Association (ADA) recommendation as study group and age and sex matched non diabetic patients.

  3. Patients whose records of FBS, PPBS and HbA1c for preceding 9 months are available.

Exclusion criteria

  1. Ocular trauma

  2. Mature or hyper mature cataract

  3. Corneal opacities obscuring view

  4. History of any ocular surgery/ laser therapy

  5. Pregnant patients

  6. Secondary diabetes (acromegaly, Cushing’s syndrome)

  7. Narrow angle glaucoma

  8. Any corneal diseases

Data collection methods

This observational study will be conducted in diabetes mellitus patients in the age group 35 to 75 years and age and sex matched non diabetic patients attending the ophthalmology and medicine OPD of Azeezia Institute of Medical science & research, Kollam.

Cases will be defined according to the following ADA recommendations:

  1. FBS ≥126 mg/dl (7.0 mmol/l). (Fasting defined as no caloric intake for at least 8 h.),

  2. Or two-hour plasma glucose ≥ 200 mg/dl (11.1 mmol/l) during an OGTT. The test will be performed as described by the world health organization, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water.

  3. Or in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a random plasma glucose ≥200 mg/dl (11.1 mmol/l).

  4. Or HbA1c ≥ 6.5%.

Venous blood will be collected into a test tube containing fluoride (fluoride inhibits glycolysis). HbA1c will be estimated by using nycocard HbA1c kit (USA). Fasting and postprandial plasma glucose will be measured using glucose oxidase peroxidase method using R1 (phosphate buffer, glucose oxidase, peroxidase and phenol, 4-aminoantipyrine) and R2 (phosphate buffer) reagent. Values of HbA1c, FBS, and PPBS of last 9 months will be obtained from patient record.

Duration of diabetes mellitus, history of any ophthalmic surgical intervention, laser therapy, pregnant state, age, sex, occupation, education and socioeconomic status will be obtained by investigator administered questionnaire.

The exclusion criteria’s will be picked up by clinical examination and slit lamp examination.

Diabetic retinopathy will be assessed by doing fundus examination by using indirect ophthalmoscope, direct ophthalmoscope and slit lamp biomicroscopic examination with 90D lens after pupillary dilatation with tropicacyl plus or homatropine.

Diabetic retinopathy will be diagnosed using modified early treatment diabetic retinopathy study (EDRTS) scale. 19

The central corneal thickness will be measured using ultrasound pachymetry after instilling topical anesthetic agent (proparacaine 0.5%). Four consecutive readings will be taken. First reading is used for patient adaptation to procedure. Mean of successive three readings will be considered for analysis and will be calculated as the measured central corneal thickness in microns (μm).

IOP will be determined by a slit lamp mounted Goldmann applanation tonometer.

Data entry and analysis

Data entry will be done using Microsoft office excel 2016. A p value of ≤ 0.05 will be considered statistically significant.

Statistical analysis

Chi square, Student’s t test.

Statistical software

MS Excel, SPSS version 17.0 was used to analyze data.

After obtaining ethical committee clearance, patients are invited to participate in the study after providing them details regarding the study. Written informed consent is obtained. Subject confidentiality is maintained.

Results

Data was entered into Microsoft excel data sheet and was analyzed using SPSS for Windows (Statistical Presentation System Software, SPSS Inc.) version 17.0.

Continuous data was represented as mean and standard deviation.

Graphical representation of data

MS Excel and MS word were used to obtain various types of graphs such as bar diagram and Pie diagram.

P value (Probability that the result is true) of <0.05 was considered as statistically significant after assuming all the rules of statistical tests.

Statistical software

MS Excel, SPSS version 17.0, Quick P value calculator online software were used to analyze data.

Total number of the study group was 212 in the age group of 35- 75 years, out of them 106 were having DM (50%). Mean age of the study group was 56 +/-11years (youngest was 35 years and oldest were 75years of age). Mean CCT was 515.67+/-29.08 um in right eye (minimum CCT was 479um and maximum were 617 um) and 551.60+/-29.32 um in left eye (minimum CCT was 480um and maximum were 647um). Mean IOP was 17+/-3.47 mmHg in right eye (lowest IOP was 12mmHg and highest were 26mmHg) and 18 +/- 5.65 mmHg in left eye (lowest IOP was 10mmHg and highest were 38 mmHg).Mean true IOP was 16.9+/- 3.66 mmHg in right eye (lowest IOP was 8.9mmHg and highest were 25.6mmHg) and 17.60 +/- 5.82 mmHg in left eye (lowest IOP was 8.5 mmHg and highest were 38.2mmHg). In our study for convenience we are taking the CCT, IOP and true IOP as means of those between right and left eye. The mean CCT was 551.63+/- 28.53 um (minimum mean CCT was 479.5um and maximum were 632um), mean IOP was 17.81 +/- 4.07 mmHg (lowest mean IOP was 12 mmHg and highest were 30mmHg) and mean true IOP was 17.28 +/- 4.22 mmHg (lowest mean true IOP was 9.35 mmHg and highest were 29.6mmHg).(Table 1)

There were 120 female (57%) and 92 males (43%) in our study. Out of the 212 subjects 65 (31%) were less than 50 years and 147 (69%) were above 50 years of age.(Table 2)

Among the total study group diabetic patients constitute 50 % (n= 106 persons).

The mean duration of diabetes mellitus was 8.2+/- 4.2 years (minimum duration was 2 years and maximum was 17 years). The mean FBS value in diabetic group was 146+/-37.4 mg/dl (lowest value was 101mg/dl and highest was 299 mg/dl) and mean PPBS was 184.51+/- 57.33mg/dl (lowest PPBS value was 130mg/dl and highest was 410 mg/dl). The mean HbA1C level was 6.98+/-1.5 (lowest HbA1C level was 5.9 and highest was 14.7). The mean true IOP was 18.78+/- 4.67 mmHg (lowest true IOP was 10.8mmHg and highest were 29.6mmHg). (Table 3).

Out of the 106 diabetic cases in our study females were 55% (58), males were 45% (48). 13(12%) were less than 50 years and 93 (88%) were above 50 years of age. Considering the duration of diabetes 36(33%) were having diabetes for less than 5 years and 70(67%) were having it for more than 5 years. 33(31%) have diabetic retinopathy changes, 73 (69%) don’t have diabetic retinopathy changes on fundus examination. Among them 21 had mild DR (64%), 8 (24%) had moderate DR and 4 (12%) had PDR. HbA1C level was high (above 6.5) in 75% (n = 80) and was normal in 25% (n = 26). FBS values were high (>126mg/dl) in 82% (n = 77) and were normal in 23% (n = 24). PPBS values were high (>140mg/dl) in 91% (n = 96) and were normal in 9% (n = 10). Mean true IOP was above 16mmHg in 77% (n = 82) and below 16mmHg in 23 % (n = 24) of diabetic patients. (Figure 1, Figure 2).

Mean CCT about 4um thicker in diabetic patients than non-diabetic subjects in our study. It was 553.44um in diabetics (standard deviation 28.73) and 549.85um in non-diabetics (standard deviation28.65). But it was not statistically significant at p value <0.5 (P value was 0.18). (Table 4)

There was statistically significant thickening of 24um in CCT with advancing grades of DR according to our study (P value 0.0001). Mean CCT was 535.45+/- 1.39 um in mild DR and 559.16+/-7.46 um in combined moderate DR and PDR subjects. (Figure 3).

Mean CCT was thicker by 7um in diabetic persons above 50 years of age. It was 547+/- 26.78 um in persons below 50 and 554+/- 29.25 um in persons above 50 years of age in our study, but it was not statistically significant (P value 0.24).(Figure 4).

Mean CCT was 552.25+/-28.58 um in females and 555.58+/-29.56 um in males. There was no statistically significant association between CCT and gender in our study (P value 0.27). (Table 5 ).

Mean CCT found to be thicker with duration of DM. Mean CCT was 552.94 +/-27.34um in less than 5 years of DM and 553.7+/-29.60 um in more than 5 years of DM. P value was 0.44, so was not statistically significant.(Table 6).

Mean CCT thickens with higher values of FBS. Mean CCT was 545.75+/-33.25 um in those with normal FBS and was 555.69+/- 27.08 um in those with high FBS. But it was not significant statistically (P value 0.6). (Figure 5).

The mean CCT was 553.66+/-28.47um in diabetics with PPBS higher than 140mg/dl and 551.1+/-32.61um with normal PPBS values. But this result was not significant statistically (P value 0.3). (Figure 6).

There was statistically insignificant thickening of mean CCT with high HbA1C values (553.96+/-28.29um than 551.84+/-30.57um in those with normal HbA1C; P value 0.37). (Figure 7).

There was no statistically significant association between CCT and DM in our study (P value 0.15). Mean CCT was 548.16+/-33.76um in DM with IOP < 16mmHg and 554.98um+/-27um in diabetics with IOP > 16mmHg. (Table 7).

Figure 1

Graphical representation of descriptive details of DM study group

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image1.png
Figure 2

Graphical representation of DM study group.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image2.png
Figure 3

Graphical representation of comparative details between CCT and different grades of DR

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image3.png
Figure 4

Graphical representation of comparative details between CCT and different age group.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image4.png
Figure 5

Graphical representation of comparative details CCT and FBS

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image5.png
Figure 6

Graphical representation of comparative details of CCT with PPBS.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image6.png
Figure 7

Graphical representation of comparative details of CCT and HbA1C

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/c5c75ccd-948e-48ae-ba7e-534f3ffcef11image7.png
Table 1

Descriptive details of the participants of the study

Group

N

Mean

Standard deviation

Minimum

Maximum

Age

212

56.25472

11.01319.

33

75

CCT RE

212

551.6698

29.08403.

479

617

CCT LE

212

551.6085

29.32289.

480

647

Mean CCT

212

551.6392

28.53053.

479.5

632

IOP RE

212

17.43396

3.46962.

12

26

IOP LE

212

18.18868

5.6453.

10

38

Mean IOP

212

17.81132

4.07132.

12

30

True IOP RE

212

16.97406

3.66765.

8.9

25.6

True IOP LE

212

17.60519

 5.82142.

8.

38.2

Mean true IOP

212

17.28962

4.22317.

9.35

29.6

Table 2

Descriptive details of the age and gender of the participants.

Frequency

Percent

Gender

Female

120

57

Male

92

43

Age

</=50 years

65

31

>50 years

147

69

Table 3

Descriptive details of the diabetic study group

Group

N

Mean

Std. Deviation

Minimum

Maximum

Duration in years

106

8.226415

4.19815.

2

17

FBS

106

146.85

37.39029.

101

299

PPBS

106

184.51

57.33598.

130

410

HbA1C

106

6.975

 1.58095.

5.9

14.7

IOP

106

18.7783

4.66596.

10.8

29.6

Table 4

Comparative details between CCT and DM

Variable

Diabetes mellitus

N

Mean

Standard deviation

Standard error

P-value

Mean CCT

Yes

106

553.4434

28.73179.

2.79068

0.18

No

106

549.8491

28.65054.

2.78279

Table 5

Comparative details between CCT and gender

Variable

Gender

N

Mean

Standard Deviation

Standard Error

P-value

CCT

Female

58

552.2586

28.58893.

 3.75391

0.279292.

Male

48

555.5833

29.56643.

4.26755

Table 6

Comparativedetails between CCT and duration

Variable

Duration

N

Mean

Standard Deviation

Standard Error

P-value

CCT

</=5

36

552.9444

 27.34483.

4.55747

0.449349

>5

70

553.7

 29.60971.

3.53904

Table 7

Comparative details between CCT and IOP

Variable

IOP

N

Mean

Standard Deviation

Standard Error

P-value

CCT

<16

24

548.1667

33.76603

6.89246

0.154299

>/=16

82

554.9878

27.12386

 2.99533

Discussion

This observational study was conducted among 106 diabetes mellitus patients and similar number of non-diabetic patients with in the age group 35 to 75 years (total 212 subjects). Out of them, majority were female; female- 120 (57%), male- 92(43%). Mean age of study population was 56 +/- 11years. For convenience mean CCT and mean true IOP of that of right and left eye was taken for this study. Mean CCT was 551+/-28um and mean true IOP was 17+/- 4mmHg in our study.

There was no statistically significant association between CCT and DM according to our study. But mean CCT was thicker in diabetic patients compared to non-DM and it was 553.44 +/- 28.73 um in DM and 549 .84 +/- 28.65 um in non-DM. Our findings agree with the findings of Sudhir and et al study conducted among 1191 DM and 121 non-DM cases, who also observed no significant association between DM and CCT. 20 In a similar study conducted by Mm Choo and et al among 100 diabetic and 100 non-diabetic patients, also showed Type II diabetes causes no significant alteration in central corneal thickness.14 But according to a study conducted by Ozdamar Yasemin and et all in with 100 DM and 145 non-DM patients, diabetic patients had thicker central corneas when compared with nondiabetic patients (mean CCT 564±30um in DM groups, 538±35um in non- DM group and P value was 0.001). 21 Daniel H.W. Summed and et al, 10 Kenji Inoue  and et al22 and J Siribunkum and et al, 23 Claramonte P. J and et al, 24 J S Lee and et al 25 and A M Roszkowska  and et al 26 also reported that there was significant thickening of cornea in diabetic patients as compared to non-diabetic patients in their studies.

There was statistically significant association between CCT and higher grades of DR according to our study (P value 0.000165). Mean CCT was 535.45+/-6.38 um in mild DR and 559.1667 +/- 25.86 um in moderate DR+ PDR combined together. This findings were similar to the findings of Ruchi Dabas and et al in their study conducted among 86 DM cases and 86 non- DM controls, where mean CCT was found to be significantly thicker in DM with DR (mean CCT was 588.20+/-16.73um in DM with DR and 553.54+/-28.07 um in DM without DR: P value 0.0001). 27 Arjun Baidya and et all found similar results in their study conducted among 124 DM cases and 65 controls( mean CCT was 572.13±17.50 um in PDR patients compared to 553.78±8.80 um in NPDR patients and showed a statistically significant association)(24). But Ozdamar and et al, 21 OKAN TOYGAR, 19 Kenji Inoue  and et al 22 and Amira El-Agamy and et al13 found no significant association of CCT with different grades of DM.

Among our diabetic study group 13 were below 50 years and 93 were above 50 years. Older persons with DM had thicker corneas than younger DM, but it was not statistically significant according to our study (mean CCT was547+/-26um in less than 50 years and it was 559+/-25 um in more than 50 years of age. These findings are in agreement with J.Gros-Otero and et al findings in their study. 28, 29 According to Solani D. Mathebula and et al mean CCT was significantly thicker in older DM cases in their study among 65 DM cases and 50 healthy controls.30 Strobbe and et all also got similar findings in their study in contrast to our observations. 31

Among the 106 diabetic patients in our study, 58(55%) were females and 48(45%) were males. There was no statistically significant association between gender and CCT in our diabetic study group. Mean CCT was 552.25+/-28.58 um in females and 555.58 +/-29.56 um in males. These findings agree with Nikhil S Choudhari and et al’s observation in their study conducted among 196 cases (84 males and 112 females; mean CCT was 527 ± 34um in males and 525 ± 33um in female) where also, there was no significant association between CCT and gender in DM (P = 0.63, two-tailed t-test). 32 Allan Storr‐Paulsen and et al, 33 Lekskul M and et al, 34 Eghosasere Iyamu and et al 35 and Strobbe and et all’s observations also agree with our findings. 31 But James D Brandt and et all reported that female gender was associated with thicker central corneas according to their study. 36 In contrast Mitsugu Shimmyo and et all reported a significant thinning of CCT in females as per an observational retrospective cross-sectional study conducted among 1976 eyes.37

Mean duration of diabetes in our diabetic patients’ group was 8 years, 36 had diabetes for less than 5 years and 70 had it for more than 5 years. We found no significant association between mean CCT and duration. Mean CCT was 552.94+/-27.34um in group having DM for less than 5 years and 553.7 +/- 29.6 um in group having DM for more than 5 years. Handan Canan AND et al’s study findings were similar in this perceptive, which was conducted among 96 DM cases. 38 Rashmi Kumari and et al also agree with our this findings with their study results conducted among 50 DM and 50 non- DM subjects (mean CCT was 576.89 ±16.87um in persons with monger duration of DM and it was 548.76 ±25.78 um in persons with shorter duration of DM, but this difference was not statistically significant (P value =0.115)). 39

Mean FBS was 146.85 +/-37.39 mg/dL, mean PPBS was 184.51 +/- 57.33 mg/dL and mean HbA1C was 6.975 +/- 1.5885. In our study we found not significant association between mean CCT and high FBS, PPBS and HbA1C values (P values 0.06, 0.39 and 0.37 respectively). Mean CCT with high FBS values (>126mg/dL) was 555.69+/-27.08 um and with normal FBS value (<126mg/dL) was 545.75+/-33.25um in our study group. Mean CCT was 553.68+/-28.47um in those with high PPBS (>140mg/dL) and 551.1+/- 32.61um in those with normal PPBS (<140mg/dL). Those with high HbA1C values had mean CCT of 553.96+/-28.29um and those with normal HbA1C had mean CCT 551.84 +/- 30.57 um. Rashmi Kumari and et al agree with these findings in her study done in 50 DM and 50 non DM controls, where mean CCT was 548.12 +/- 21.7um in those with normal HbA1C and 568.22 +/-18.5um in those with high HbA1C(P value =0.231, statistically not significant).39 Yasemin Ozdamar and et al also stated no significant association between CCT and HbA1C as per a study conducted among 100 DM and 145 healthy controls.21 Allan Storr‐Paulsen also reported that HbA1c did not have any impact on the CCT.33  But according to Su and et al10 there was significant correlation between corneal thickness and the higher HbA1C and reported that cornea was thicker with high HbA1C.

Mean CCT found to be high in those with IOP > 16 mmHg, but was not statistically significant in our study (P value 0.15). Mean CCT was 554.98+/- 27.12um in those having IOP more than 16 mmHg and 548.16+/-33.76 in those with IOP less than 16 mmHg. Handan Canan and et al reported similar results in their study done among 96 DM patients (P = 0.241,no significant association between IOP and mean CCT in DM).38 But in an instance Okan Toygar and et al stated that there was significant association between CCT and IOP in DM in a study conducted among 160 DM and 52 non DM cases (P < 0.01).40 These findings are similar to Anselm Hennis and et al41 and DiZhao and et al42 observations in their study.

Conclusion

Cornea is the major refractive surface of eye, even subtle changes in it can seriously affect the optical clarity. CCT is an important parameter for glaucoma. IOP is very significantly affected by its value while measuring with Goldmann applanation tonometry (and Goldmann applanation tonometry is the gold standard for measuring IOP). CCT is also an important factor for refractive surgeries, donor tissue evaluation prior to keratoplasty and in long term contact lens users. Many studies were done in the field of ocular manifestations of diabetes mellitus, including the effect of DM in CCT and observed both positive and negative correlation between the same. This study is a small effort to determine if there is any relationship between diabetes and CCT in type 2 DM and normal persons. And our study concluded no significant association between central corneal thickness and CCT. But there was statistically significant association between CCT and different grades of DR as per our study. Even though mean CCT was thicker with high FBS, PPBS, HbA1C values and higher IOP, it was not statistically significant. Females showed a statistically insignificant thinning compared to males in our DM study groups. Age and duration of DM also showed no association with mean CCT. Many related studies were done in the past, but with inconsistent results. It may be because of the large standard deviation of mean CCT in our population and may be due to effect of age, sex, ethnicity, and ocular and systemic diseases over the CCT (but many are not proven satisfactorily). Hence, a more detailed evaluation and research is needed in this area for a better understanding of effect and pathogenesis of DM over CCT for better assessment of diabetic cornea.

Conflicts of interest

None.

Conflict of Interest

None.

References

1 

JH Park JH Moon HJ Kim MH Kong YH Oh Sedentary Lifestyle: Overview of Updated Evidence of Potential Health RisksKorean J Fam Med202041636573

2 

VJ Vieira-Potter D Karamichos DJ Lee Ocular Complications of Diabetes and Therapeutic ApproachesBiomed Res Int2016380157010.1155/2016/3801570

3 

G Bikbova T Oshitari A Tawada S Yamamoto Corneal Changes in Diabetes MellitusCurr. Diabetes Rev201284294302

4 

RP Maurya Diabetic Retinopathy: My Brief SynopsisIndian J Clin Exp Ophthalmol 20151418990

5 

N Ducrey Ocular lesions due to diabetesSchweiz Med Wochenschr19961263816102

6 

Diabetic keratopathyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312182/[accessed 2020-11-18]

7 

M Göbbels M Spitznas J Oldendoerp Impairment of corneal epithelial barrier function in diabeticsGraefes Arch Clin Exp Ophthalmol198922721424

8 

Tear function and ocular surface changes in noninsulin-dependent diabetes mellitushttps://pubmed.ncbi.nlm.nih.gov/11237914[Accessed 2020-11-18]

9 

GN Foulks RA Thoft HD Perry FI Tolentino Factors Related to Corneal Epithelial Complications after Closed Vitrectomy in DiabeticsArch Ophthalmol1960197997610768

10 

DHW Su TY Wong WL Wong SM Saw DTH Tan SY Shen Singapore Malay Eye Study Group. Diabetes, Hyperglycemia, and Central Corneal Thickness: The Singapore Malay Eye StudyOphthalmology200811569648

11 

XY Luo W Dai ML Chee Y Tao J Chua NYQ Tan Association of Diabetes With Central Corneal Thickness Among a Multiethnic Asian PopulationJAMA Netw Open201921e18664710.1001/jamanetworkopen.2018.6647.

12 

HMK Elsobky FMW Farid EEM El-Sayed Corneal endothelial and central corneal thickness changes in patients with type II diabetes mellitusMenoufia Med J2018314131723

13 

A El-Agamy S Alsubaie Corneal Endothelium and Central Corneal Thickness Changes in Type 2 Diabetes MellitusClin Ophthalmol201711481610.2147/OPTH.S126217

14 

M Choo K Prakash A Samsudin T Soong N Ramli A Kadir Corneal Changes in Type II Diabetes Mellitus in MalaysiaInt J Ophthalmol201033234610.3980/j.issn.2222-3959.2010.03.12

15 

XY Luo W Dai ML Chee Y Tao J Chua NYQ Tan Association of Diabetes With Central Corneal Thickness Among a Multiethnic Asian PopulationJAMA Netw Open201921e18664710.1001/jamanetworkopen.2018.6647

16 

Human Corneal Thickness and Its Impact on Intraocular Pressure MeasuresSurvey Ophthalmol200445367408

17 

M Kohlhaas AG Boehm E Spoerl A Pürsten HJ Grein LE Pillunat Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometryArch Ophthalmol196012444716

18 

S Prabhakar, B Mahesh M Shanthamallappa A comparative study of intraocular pressure measurement by three tonometers in normal subjectsNepalese J Ophthalmol2013522016

19 

L Wu P Fernandez-Loaiza J Sauma E Hernandez-Bogantes M Masis Classification of Diabetic Retinopathy and Diabetic Macular EdemaWorld J Diabetes2013462904

20 

RR Sudhir R Raman T Sharma Changes in the Corneal Endothelial Cell Density and Morphology in Patients With Type 2 Diabetes Mellitus: A Population-Based Study, Sankara Nethralaya Diabetic Retinopathy And Molecular Genetics Study (SN-DREAMSCornea20123110111922

21 

Y Ozdamar B Cankaya S Ozalp G Acaroglu J Karakaya S S Özkan Is there a correlation between diabetes mellitus and central corneal thickness?J Glaucoma20101996136

22 

K Inoue S Kato Y Inoue S Amano T Oshika The corneal endothelium and thickness in type II diabetes mellitusJpn J Ophthalmol2002461659

23 

J Siribunkum P Kosrirukvongs A Singalavanija Corneal abnormalities in diabetesJ Med Assoc Thai2001848107583

24 

P Claramonte J Ruiz-Moreno S Sánchez-Pérez M León C Griñó VD Cerviño Variation of Central Corneal Thickness in Diabetic Patients as Detected by Ultrasonic PachymetryArch Soc Esp Oftalmol20068195236

25 

JS Lee BS Oum HY Choi JE Lee BM Cho Differences in Corneal Thickness and Corneal Endothelium Related to Duration in DiabetesEye Lond Engl20062033158

26 

AM Roszkowska CG Tringali P Colosi CA Squeri G Ferreri Corneal Endothelium Evaluation in Type I and Type II Diabetes MellitusOphthalmologica1999213425861

27 

R Dabas S Sethi M Garg R Aggarwal S Lamba A Bhattacharjee Comparison of the central corneal thickness in diabetes mellitus patients and non diabetics individualsAnn Int Med Dent Res20172546

28 

J Gros-Otero C Arruabarrena-Sánchez M Teus Central Corneal Thickness in a Healthy Spanish PopulationArch Soc Esp Oftalmol2011863736

29 

A Baidya QS Waheed AD Sarkar 571-P: A Cross-Sectional Observational Study on Correlation between the Central Corneal Thickness and Diabetic Retinopathy Diabetes 202069Supplement_157110.2337/db20-571-P

30 

SD Mathebula TM Segoati Is the central corneal thickness of diabetic patients thicker than that of non-diabetics’ eyes?Afr Vision Eye Health201574130710.4102/aveh.v74i1.307

31 

E Strobbe M Cellini U Barbaresi EC Campos Influence of Age and Gender on Corneal Biomechanical Properties in a Healthy Italian PopulationCornea201433996872

32 

NS Choudhari R George RV Sathyamangalam P Raju R Asokan L Velumuri Long-Term Change in Central Corneal Thickness from a Glaucoma PerspectiveIndian J Ophthalmol201361105824

33 

A Storr-Paulsen A Singh H Jeppesen JC Norregaard J Thulesen Corneal Endothelial Morphology and Central Thickness in Patients with Type II Diabetes MellitusActa Ophthalmol (Copenh)201492215860

34 

M Lekskul P Aimpun B Nawanopparatskul S Bumrungsawat T Trakulmungkijkarn J Charoenvanichvisit The correlations between Central Corneal Thickness and age, gender, intraocular pressure and refractive error of aged 12-60 years old in rural Thai communityPLoS One20058831759

35 

Age, gender, corneal diameter, corneal curvature and central corneal thickness in Nigerians with normal intra ocular pressure - ScienceDirecthttps://www.sciencedirect.com/science/article/pii/S1888429612000210[Accessed 2020-11-27]

36 

JD Brandt JA Beiser MA Kass MO Gordon Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS)Ophthalmology200110810177988

37 

M Shimmyo AJ Ross A Moy R Mostafavi Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African AmericansAm J Ophthalmol2003136460313

38 

H Canan N Sahinoglu-Keskek R Altan-Yaycioglu The Relationship of Central Corneal Thickness with the Status of Diabetic RetinopathyBMC Ophthalmol202020122010.1186/s12886-020-01411-2

39 

R Kumari BC Saha Central Corneal Thickness and Diabetes – A Study of Correlation in Terms of Duration and Glycemic ControlInt J Contemp Med Res2015437679

40 

O Toygar S Sizmaz A Peli̇t B Toygar ÖY Kiziloğlu Y Akova Central Corneal Thickness in Type II Diabetes Mellitus: Is It Relatedto the Severity of Diabetic Retinopathy? TurkTurk J Med Sci20154536514

41 

A Hennis SY Wu B Nemesure MC Leske Hypertension, Diabetes, and Longitudinal Changes in Intraocular PressureOphthalmology2003110590814

42 

D Zhao J Cho MH Kim DS Friedman E Guallar Diabetes, Fasting Glucose, and the Risk of Glaucoma: A Meta-AnalysisOphthalmology20151221728



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 13-09-2023

Accepted : 18-10-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijooo.2023.042


Article Metrics






Article Access statistics

Viewed: 697

PDF Downloaded: 353



Medical Abbreviation List